Intellia Therapeutics (NTLA) PT Lowered to $40 at Oppenheimer
Tweet Send to a Friend
(Updated - January 13, 2025 7:42 AM EST)
Oppenheimer analyst Jay Olson lowered the price target on Intellia Therapeutics ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Oppenheimer analyst Jay Olson lowered the price target on Intellia Therapeutics ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
